Gyre Therapeutics Inc (GYRE)

Oct 22, 2024

Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis - The Manila Times

Oct 22, 2024

Oct 22, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 3.8%What's Next? - MarketBeat

Oct 22, 2024

Oct 14, 2024

AQR Capital Management LLC Invests $778,000 in Mativ Holdings, Inc. (NYSE:MATV) - Defense World

Oct 14, 2024

Oct 08, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap UpStill a Buy? - MarketBeat

Oct 08, 2024

Oct 03, 2024

Aligos Therapeutics (NASDAQ:ALGS) Shares Down 6.2% - Defense World

Oct 03, 2024

Oct 03, 2024

Coronation Fund Managers Ltd. Buys 1,044 Shares of The Sherwin-Williams Company (NYSE:SHW) - Defense World

Oct 03, 2024

Oct 03, 2024

Eaton Vance California Municipal Income Trust (NYSE:CEV) Major Shareholder Sells $282,451.70 in Stock - Defense World

Oct 03, 2024

Oct 03, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading 3.3% HigherHere's What Happened - MarketBeat

Oct 03, 2024

Oct 02, 2024

Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference - The Manila Times

Oct 02, 2024

Sep 18, 2024

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Down 7.0% in August - MarketBeat

Sep 18, 2024

Sep 18, 2024

Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday - Benzinga

Sep 18, 2024

Sep 17, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 4.9% - MarketBeat

Sep 17, 2024

Sep 06, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading Up 6.6% - MarketBeat

Sep 06, 2024

Sep 05, 2024

Gyre Therapeutics Inc (GYRE) Stock Price & Chart | Trade Now - Capital.com

Sep 05, 2024

Sep 04, 2024

Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com

Sep 04, 2024

Sep 03, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Down 8.9% - MarketBeat

Sep 03, 2024

Sep 02, 2024

Short Interest in Gyre Therapeutics, Inc. (NASDAQ:GYRE) Grows By 5.4% - MarketBeat

Sep 02, 2024

Aug 28, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading 4.1% Higher - MarketBeat

Aug 28, 2024

Aug 27, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Down 6.6% - MarketBeat

Aug 27, 2024

Aug 26, 2024

Gyre Therapeutics (NASDAQ:GYRE) Sees Unusually-High Trading Volume - MarketBeat

Aug 26, 2024

Aug 25, 2024

Bicara Therapeutics (NASDAQ:BCAX) Stock Quotes, Forecast and News Summary - Benzinga

Aug 25, 2024

Aug 19, 2024

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Sees Significant Growth in Short Interest - MarketBeat

Aug 19, 2024

Aug 19, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 8.2% - MarketBeat

Aug 19, 2024

Aug 19, 2024

Vanguard Group Inc. Reduces Holdings in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World

Aug 19, 2024

Aug 15, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up to $10.40 - MarketBeat

Aug 15, 2024

Aug 13, 2024

GYRE Stock Earnings: Gyre Therapeutics Reported Results for Q2 2024 - InvestorPlace

Aug 13, 2024

Aug 13, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading Down 3.9% - MarketBeat

Aug 13, 2024

Aug 13, 2024

Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update - BioSpace

Aug 13, 2024

Aug 12, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading 6.7% Higher - MarketBeat

Aug 12, 2024

Aug 09, 2024

Gyre Therapeutics to Present at Sidoti Virtual Investor Conference - ForexTV.com

Aug 09, 2024

Aug 08, 2024

Gyre Therapeutics Welcomes Dr. Epstein to Leadership Team - TipRanks

Aug 08, 2024

Aug 08, 2024

Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors - StockTitan

Aug 08, 2024

Aug 07, 2024

Gyre Therapeutics (NASDAQ:GYRE) versus Insmed (NASDAQ:INSM) Critical Comparison - Defense World

Aug 07, 2024

Aug 06, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 8.4% - MarketBeat

Aug 06, 2024

Aug 05, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 18.9% - MarketBeat

Aug 05, 2024

Jul 30, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 8.4% - MarketBeat

Jul 30, 2024

Jul 29, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading Up 4.9% - MarketBeat

Jul 29, 2024

Jul 26, 2024

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Up 67.9% in July - MarketBeat

Jul 26, 2024

Jul 21, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Down 4.3% - Defense World

Jul 21, 2024

Jul 19, 2024

Gyre Therapeutics (NASDAQ:GYRE) Trading Down 4.3% - MarketBeat

Jul 19, 2024

Jul 18, 2024

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Update - Defense World

Jul 18, 2024

Jul 18, 2024

Supply@ME Capital (LON:SYME) Stock Price Up 16.7% - Defense World

Jul 18, 2024

Jul 15, 2024

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Short Interest Update - Defense World

Jul 15, 2024

Jul 15, 2024

Head to Head Comparison: Puma Biotechnology (NASDAQ:PBYI) versus Gyre Therapeutics (NASDAQ:GYRE) - Defense World

Jul 15, 2024

Jul 15, 2024

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Short Interest Up 15.1% in June - Defense World

Jul 15, 2024

Jul 14, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 5.5% - Defense World

Jul 14, 2024

Jul 08, 2024

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 4.3% - MarketBeat

Jul 08, 2024

Jul 07, 2024

Gyre Therapeutics (NASDAQ:GYRE) Shares Up 3.7% - Defense World

Jul 07, 2024

Jul 06, 2024

Gyre Therapeutics faces Nasdaq delisting over audit rule - Investing.com India

Jul 06, 2024

Jul 05, 2024

Gyre Therapeutics faces Nasdaq delisting over audit rule By Investing.com - Investing.com

Jul 05, 2024

Jul 05, 2024

Gyre Therapeutics Seeks Compliance Amid Board Reshuffle - TipRanks

Jul 05, 2024